logo
Select company
Select metric
$ -2.18MInterest Expense
VS
Market
98
Sector
98
Industry
98
History
95
$ 13.95Close
$ 3.59 - $ 14.97 52-Week Range
Ticker Information

Ticker

AVTX

Company Name

AVALO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AVALO THERAPEUTICS INC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AVTX - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ -2.18M
3/31/2025$ -3.22M
12/31/2024$ -3.32M
9/30/2024$ -2.08M
6/30/2024$ 433K
3/31/2024$ 2.47M
12/31/2023$ 3.42M
9/30/2023$ 4.45M
6/30/2023$ 3.79M
3/31/2023$ 3.95M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AVALO THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. stands at $ -613.62K.
  • Over the past 5 years, AVALO THERAPEUTICS INC's average Int. Exp. has been $ 1.38M.
  • The median Int. Exp. for AVALO THERAPEUTICS INC during this period was $ 1.81M
  • AVALO THERAPEUTICS INC reached its highest Int. Exp. over the past 5 years at $ 4.49M.
  • The lowest Int. Exp. recorded by AVALO THERAPEUTICS INC in the same timeframe $ -3.32M

AVALO THERAPEUTICS INC's Int. Exp. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. Benchmarks
CompanyInt. Exp.
COYA : COYA THERAPEUTICS INC $ 0ABVC : ABVC BIOPHARMA INC $ 233.56KVTGN : VISTAGEN THERAPEUTICS INC $ 0RPTX : REPARE THERAPEUTICS INC $ 0INO : INOVIO PHARMACEUTICALS INC $ 0ENTX : ENTERA BIO LTD $ 0COEP : COEPTIS THERAPEUTICS HOLDINGS INC $ 268.83KIBIO : IBIO INC $ 212KPULM : PULMATRIX INC $ 0ERNA : ERNEXA THERAPEUTICS INC $ 5.16M

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

AVTX - Interest Expense, Last 5 years

$ -3.32M

Minimum

Dec 31, 2024

$ 4.49M

Maximum

Jun 30, 2022

$ 1.38M

Average

$ 1.81M

Median

Int. Exp. Benchmark Analysis

The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.81M with a standard deviation of $ 5.59M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.73K
min$ -15.41M
max$ 23.09M
average$ 2.81M
median$ 19.42K
std$ 5.59M